Athmic Biotech Solutions Pvt Ltd is involved in biological sample testing services and research consultancy in various fields such as Biotechnology, Biochemistry, Microbiology, and Molecular Biology, self-described.

Athmic Biotech Solutions Pvt Ltd

Eurofins Advinus offers contract research services in drug discovery, preclinical, and development stages, including manufacturing drug substances for Toxicology and clinical studies. It serves diverse industries such as Biotech, Pharmaceutical, and Agrochemical.

Eurofins Advinus

SPECTRO Analytical provides elemental analysis solutions including spectrometers and associated technologies for various industries.

SPECTRO Analytical

Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States, and internationally. The company provides discovery chemistry services, such as medicinal and synthetic chemistry, library and peptide synthesis, biomolecules, organic electronic materials, and computational and analytical chemistry; and discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals. It also offers exploratory/discovery, in vitro and genetic, and developmental and reproductive toxicology services, as well as acute, sub-chronic, and chronic toxicity studies; and chemical, formulation, analytical, and clinical development services, as well as commercial manufacturing services. In addition, the company provides lead generation, preclinical development, API, and drug product development services; and clinical trial management, pharmacokinetic analysis/bioanalytical, central lab, biometrics and clinical data management, regulatory, medical monitoring, pharmacovigilance, and medical writing services. Further, it offers other drug modalities, which include peptides, oligonucleotide synthesis, antibody drug conjugate, PROTACs, and CAR T-cell therapy services. The company serves pharmaceutical, biotechnology, nutrition, animal health, consumer goods, specialty chemical, and other companies. It has partnerships and collaborations with Bristol-Myers Squibb Co.; Baxter Inc.; and Amgen Inc. The company was incorporated in 1993 and is headquartered in Bengaluru, India. Syngene International Limited is a subsidiary of Biocon Limited.

Metric
Company Name	Athmic Biotech Solutions Pvt Ltd	Eurofins Advinus	SPECTRO Analytical	Syngene International Limited
Symbol				SYNGENE
MSH ID	COM:ATHMICBIOTECH	COM:ADVINUS	COM:SPECTRO	COM:SYNGENEINTL
Market	PRIVATE	PRIVATE	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare & Health Services	Technology	Healthcare
Industry	Biotechnology	Pharmaceuticals	Analytical Instruments	Biotechnology
Country	IN	IN	DE	IN
Stage
Employee Count			501	6.51K
Website	athmicbiotech.com	advinus.com	spectro.com	syngeneintl.com
LinkedIn
Founders

Metric
Market Cap				3.49B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue				411.87M
Revenue (LTM)
Revenue (NTM)
Gross Profit				146.84M
EBITDA				126.35M
Operating Income				76.07M
Net Income				60.21M
EPS				0.15
Diluted EPS				0.15
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin				0.71
Operating Profit Margin				0.20
EBITDA Margin				0.31
Net Profit Margin				0.15
Return on Equity				0.13
Return on Assets				0.09
Return on Capital Employed				0.14

COM:ATHMICBIOTECH

Athmic Biotech Solutions Pvt Ltd

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio				59.46
P/B Ratio				7.64
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio				10.85
EV Multiple				35.87

Metric
Days Sales Outstanding				46.41
Days Payables Outstanding				99.94
Days Inventory Outstanding				94.68
Operating Cycle				136.18
Cash Conversion Cycle				41.32
Asset Turnover				0.62

Metric
Operating Cash Flow				129.25M
Free Cash Flow				68.95M
Cash Flow to Debt				4.32
Operating Cash Flow/Sales				0.24
Free Cash Flow Yield

Metric
Cash & Equivalents				66.53M
Accounts Receivable				10.24M
Inventory				28.16M
Goodwill
Debt to Capitalization				0.08
Debt to Assets				0.14
Current Ratio				1.94
Quick Ratio				1.70

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue